Cargando…

Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome

ABSTRACT: There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium...

Descripción completa

Detalles Bibliográficos
Autores principales: Duggan, William P., Salvucci, Manuela, Kisakol, Batuhan, Lindner, Andreas U., Reynolds, Ian S., Dussmann, Heiko, Fay, Joanna, O’Grady, Tony, Longley, Daniel B., Ginty, Fiona, Mc Donough, Elizabeth, Slade, Daniel J., Burke, John P., Prehn, Jochen H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300184/
https://www.ncbi.nlm.nih.gov/pubmed/37171483
http://dx.doi.org/10.1007/s00109-023-02324-5
_version_ 1785064532630044672
author Duggan, William P.
Salvucci, Manuela
Kisakol, Batuhan
Lindner, Andreas U.
Reynolds, Ian S.
Dussmann, Heiko
Fay, Joanna
O’Grady, Tony
Longley, Daniel B.
Ginty, Fiona
Mc Donough, Elizabeth
Slade, Daniel J.
Burke, John P.
Prehn, Jochen H. M.
author_facet Duggan, William P.
Salvucci, Manuela
Kisakol, Batuhan
Lindner, Andreas U.
Reynolds, Ian S.
Dussmann, Heiko
Fay, Joanna
O’Grady, Tony
Longley, Daniel B.
Ginty, Fiona
Mc Donough, Elizabeth
Slade, Daniel J.
Burke, John P.
Prehn, Jochen H. M.
author_sort Duggan, William P.
collection PubMed
description ABSTRACT: There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium may be especially prevalent in mucinous CRC. The objectives of this study were to assess the association of Fusobacterium abundance with immune cell composition and prognosis in mucinous CRC. Our study included two independent colorectal cancer patient cohorts, The Cancer Genome Atlas (TCGA) cohort, and a cohort of rectal cancers from the Beaumont RCSI Cancer Centre (BRCC). Multiplexed immunofluorescence staining of a tumour microarray (TMA) from the BRCC cohort was undertaken using Cell DIVE technology. Our cohorts included 87 cases (13.3%) of mucinous and 565 cases (86.7%) of non-mucinous CRC. Mucinous CRC in the TCGA dataset was associated with an increased proportion of CD8 + lymphocytes (p = 0.018), regulatory T-cells (p = 0.001) and M2 macrophages (p = 0.001). In the BRCC cohort, mucinous RC was associated with enhanced CD8 + lymphocyte (p = 0.022), regulatory T-cell (p = 0.047), and B-cell (p = 0.025) counts. High Fusobacterium abundance was associated with an increased proportion of CD4 + lymphocytes (p = 0.031) and M1 macrophages (p = 0.006), whilst M2 macrophages (p = 0.043) were under-represented in this cohort. Patients with increased Fusobacterium relative abundance in our mucinous CRC TCGA cohort tended to have better clinical outcomes (DSS: likelihood ratio p = 0.04, logrank p = 0.052). Fusobacterium abundance may be associated with improved outcomes in mucinous CRC, possibly due to a modulatory effect on the host immune response. KEY MESSAGES: • Increased Fusobacterium relative abundance was not found to be associated with microsatellite instability in mucinous CRC. • Increased Fusobacterium relative abundance was associated with an M2/M1 macrophage switch, which is especially significant in mucinous CRC, where M2 macrophages are overexpressed. • Increased Fusobacterium relative abundance was associated with a significant improvement in disease specific survival in mucinous CRC. • Our findings were validated at a protein level within our own in house mucinous and non-mucinous rectal cancer cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00109-023-02324-5.
format Online
Article
Text
id pubmed-10300184
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103001842023-06-29 Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome Duggan, William P. Salvucci, Manuela Kisakol, Batuhan Lindner, Andreas U. Reynolds, Ian S. Dussmann, Heiko Fay, Joanna O’Grady, Tony Longley, Daniel B. Ginty, Fiona Mc Donough, Elizabeth Slade, Daniel J. Burke, John P. Prehn, Jochen H. M. J Mol Med (Berl) Original Article ABSTRACT: There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium may be especially prevalent in mucinous CRC. The objectives of this study were to assess the association of Fusobacterium abundance with immune cell composition and prognosis in mucinous CRC. Our study included two independent colorectal cancer patient cohorts, The Cancer Genome Atlas (TCGA) cohort, and a cohort of rectal cancers from the Beaumont RCSI Cancer Centre (BRCC). Multiplexed immunofluorescence staining of a tumour microarray (TMA) from the BRCC cohort was undertaken using Cell DIVE technology. Our cohorts included 87 cases (13.3%) of mucinous and 565 cases (86.7%) of non-mucinous CRC. Mucinous CRC in the TCGA dataset was associated with an increased proportion of CD8 + lymphocytes (p = 0.018), regulatory T-cells (p = 0.001) and M2 macrophages (p = 0.001). In the BRCC cohort, mucinous RC was associated with enhanced CD8 + lymphocyte (p = 0.022), regulatory T-cell (p = 0.047), and B-cell (p = 0.025) counts. High Fusobacterium abundance was associated with an increased proportion of CD4 + lymphocytes (p = 0.031) and M1 macrophages (p = 0.006), whilst M2 macrophages (p = 0.043) were under-represented in this cohort. Patients with increased Fusobacterium relative abundance in our mucinous CRC TCGA cohort tended to have better clinical outcomes (DSS: likelihood ratio p = 0.04, logrank p = 0.052). Fusobacterium abundance may be associated with improved outcomes in mucinous CRC, possibly due to a modulatory effect on the host immune response. KEY MESSAGES: • Increased Fusobacterium relative abundance was not found to be associated with microsatellite instability in mucinous CRC. • Increased Fusobacterium relative abundance was associated with an M2/M1 macrophage switch, which is especially significant in mucinous CRC, where M2 macrophages are overexpressed. • Increased Fusobacterium relative abundance was associated with a significant improvement in disease specific survival in mucinous CRC. • Our findings were validated at a protein level within our own in house mucinous and non-mucinous rectal cancer cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00109-023-02324-5. Springer Berlin Heidelberg 2023-05-12 2023 /pmc/articles/PMC10300184/ /pubmed/37171483 http://dx.doi.org/10.1007/s00109-023-02324-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Duggan, William P.
Salvucci, Manuela
Kisakol, Batuhan
Lindner, Andreas U.
Reynolds, Ian S.
Dussmann, Heiko
Fay, Joanna
O’Grady, Tony
Longley, Daniel B.
Ginty, Fiona
Mc Donough, Elizabeth
Slade, Daniel J.
Burke, John P.
Prehn, Jochen H. M.
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title_full Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title_fullStr Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title_full_unstemmed Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title_short Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
title_sort increased fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300184/
https://www.ncbi.nlm.nih.gov/pubmed/37171483
http://dx.doi.org/10.1007/s00109-023-02324-5
work_keys_str_mv AT dugganwilliamp increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT salvuccimanuela increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT kisakolbatuhan increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT lindnerandreasu increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT reynoldsians increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT dussmannheiko increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT fayjoanna increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT ogradytony increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT longleydanielb increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT gintyfiona increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT mcdonoughelizabeth increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT sladedanielj increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT burkejohnp increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome
AT prehnjochenhm increasedfusobacteriumtumouralabundanceaffectsimmunogenicityinmucinouscolorectalcancerandmaybeassociatedwithimprovedclinicaloutcome